Saturday 26 November 2016

Report submitted to the APHRDI on the 3 days residential program on Patent laws

                                                    Sri Rama Jayam
Andhra Pradesh Human Resource Development Institute (Govt. of Andhra Pradesh)
A REPORT on

3 Day Residential Training Programme on  “Patent Law & Policy

(Sponsored by Department of Personnel & Training, Govt. of India)
Venue: AP HRDI, Bapatla, Guntur Dist.
21 - 23 November, 2016

On the outset I would like to extend my heartfelt congratulations to the APHRDI team lead by His Highness the Director General Sri D. Chakrapani sir IAS (Retd),  for providing excellent platform to enlighten the participants drawn from various government departments and private institution from the State of Andhra Pradesh.
The planning and execution of the program was meticulous. The selections of the topics as well as the Resource Persons from various prominent fields were good and extraordinary.  It was the result of the hard work and effective administration with the implementation of the high level standards.
The participants representing from diverse segments like, agriculture, pharmacy, revenue, engineering, legal and police departments were the well woven group of individuals and in the responsible  positions in their particular departments.
The accommodation and boarding facilities provided to the resource persons and as well as participants were excellent. The mess service and menu items served are very good in taste. The logistics service provided to the Resource persons were very fine and upto the mark. The auditorium also well equipped and nicely furnished to accommodate more than 100 audiences with full air condition.
The program was inaugurated by the Vice Chancellor of Acharya Nagarjuna University Professor Rajendra Prasad garu, and the first session on the first day was presented by the Registrar of NALSAR University Dr. Balakista Reddy garu on the topic WTO – World Trade Organization and TRIPS. The second session was taken by Dr. G.B.Reddy garu , of Osmania university Law college. He presented two topics in the afternoon session on copyrights and introduction to patent system.
The Second day session was started with my presentation on Patent Law and Policy and usefulness of IPRs to the engineers and scientists. The forenoon session was delivered by Dr.ChinuSinivasan on Patent Law and Policy with Reference to pharmaceuticals. The afternoon session was taken by Dr.Ramars Amanchy on the topic Ethics in DNA Patenting. In the evening the last session was taken by Mr. Ravi Katukam on Innovative Andhra Pradesh.

The Third day session was taken by Dr. Mohana Krishna , Vice Principal, Pendekanti Law College, on the topic What is Section 3 (D) of the Indian Patent Act & what are the controversies, and Liability of internet service providers for copy rights. The afternoon sessions were taken by Ms. Himabindu of Novel Patent Consultency of vizag on the topic AP Patenting / Software patenting or Whether Patent Law Protects biotechnological interventions. On the third day last session was taken by Mr. Ravi Katukam on the topic Patent Search & application.

After the completion of all the sessions the participants and the resource persons taken a group photo at APHRDI premises and at end of the program the departmental staff distributed the certificates and relieving letters to the participants.

Conclusion: - The opinion and feedback from the participants are positive and they are expecting to participate many more such sessions in the near future. The outcome of the program was well amalgamated by the audience and everyone in the participants is able to understand and propagate the need for the effective administration of the Intellectual Property Rights.

PS: - As a Resource Person and Moderator for the 3 days Residential Program, hereby I am submitting my personal views and options to my fullest and utmost satisfaction to express the effective and efficient administrative capabilities of our Director General of APHRDI.

Thanking you sir,
Yours Sincerely

Puttu Guru Prasad, VVIT, Guntur.

Patent law and Policy program at APHRDI , Bapatla.





























The 3 daus Residential Program on Patent Law and Policy held at APHRDI, Bapatal.











Thursday 17 November 2016

Profile, Bio-data, Resume, CV, of Prof. Guru-Prasad-Puttu-05-02-2016

Importance -of-IPRs...Madrid-Protocol

DIDACTICAL-Significance-of-Professor-Puttu-Guru-Prasad

List of final Ph.D students in commerce & Management JNTUK Kakinada

Schedule for the research scholars (2015-16) to finalize the Supervisors and
Co-Supervisors along with necessary documents is as follows
Department
From
To
Number of Students
Date of finalizing Supervisor & Co-supervisor
Mechanical
15022P0301
15022P0332
32
8th March, 2016
Mechanical
15022P0333
15022P0364
32
9th March, 2016
Civil Engineering
15022P0101
15022P0128
28
10th March, 2016
CSE
15022P0501
15022P0523
23
11th March, 2016
CSE
15022P0524
15022P0546
23
12th March, 2016
CSE
15022P0547
15022P0569
23
14th March, 2016
ECE
15022P0401
15022P0428
28
15th March, 2016
ECE
15022P0429
15022P0456
28
16th March, 2016
ECE
15022P0457
15022P0484
28
17th March, 2016
EEE
15022P0201
15022P0225
25
18th March, 2016
EEE
15022P0226
15022P0237
12
19th March, 2016
Chemistry
15022PCY01
15022PCY09
9
19th March, 2016
Biotechnology
15022PBT01
15022PBT02
2
19th March, 2016
Commerce
15022PCOM01
15022PCOM04
4
19th March, 2016
English
15022PEN01
15022PEN06
6
21st March, 2016
Management
15022PMG01
15022PMG08
8
21st March, 2016
Metallurgy
15022PMET01
15022PMET02
2
21st March, 2016
Pharmacy
15022PPH01
15022PPH07
7
21st March, 2016
Physics
15022PPY01
15022PPY08
8
21st March, 2016
Spatial Information Technology
15022PSIT01
15022PSIT02
2
21st March, 2016
Mathematics
15022PMT01
15022PMT26
26
22nd March, 2016
Prof.Puttu Guru Prasad,Lawyer

Usefulness-of-IPRs-Intellectual-Property-Rights

Landmark-Case-Studies-of-IPRs

Indian IPR Policy 2016 latest.

Wednesday 16 November 2016

Introduction-to-Cyber-Law

Kaiser-Wilhelm

Why-Did-the-Kaiser-Abdicate

World-War-I-2 Assassination Archduke Franz Ferdinand and Duchess Sophie at Sarajevo, Bosnia, on June 28th, 1914.

WW-1-3 The History of WW I

Causes-of-World-War-1-ppt

Treaty-of-Versailles-3, the cause of German out burst on Jewish people

Treaty-of-Versailles-the main cause of world war II

Treaty-of-Versailles , the reason for world war II

Treaty-of-Versailles2

Tuesday 15 November 2016

Generally Accepted Accounting Principles

Introduction to Financial Accounting

Basic-Accounting-Principles-and-Concepts

How-to-Increse-the-Enrollment-in-Our-School

About-Viva the International School at Nambur, AP capital Amaravathi

Research-Methodology-used-in-Social-Science-and-Management

Plagiarism-Tips-to-Avoid-Plagiarism

Innovations-in-Teaching-Research, a comparative study

Inventions-and-Innovations useful for Research

IPR Ensures Safeguards for Indian Pharma Industry

IPR Ensures Safeguards for Indian Pharma Industry

The policy comes in the backdrop of the US Trade Representative (USTR), in its annual (2016 edition) Special 301 Report (on the Global State of IPR Protection and Enforcement) retaining India on the ‘Priority Watch List’ this year for “lack of sufficient measurable improvements to its IPR framework.” Though the U.S. concerns include the “rejections” of patent applications for innovative pharmaceutical products due to “unpredictable” application of Section 3(d) of the (Indian) Patents Act, the policy ensure that no changes are made in that Section (which prevents ever-greening of drug patents) and the patent-disabling Compulsory Licensing( CL) regime.

In fact, the IPR Policy states “India shall remain committed to the (World Trade Organization’s) Doha Declaration on (WTO’s) Trade Related IPR Agreement (TRIPS) and Public Health”. There was, however, a bit of apprehension that mention of Doha Declaration and flexibility would mean there would be attempts to find loopholes in TRIPS in order to favour pharmaceutical companies. It also says “India will continue to utilize the legislative space and flexibilities available in international treaties and the TRIPS Agreement.” These flexibilities include the sovereign right of countries to use provisions such as Section 3(d) and CLs for ensuring the availability of essential and life-saving drugs at affordable prices.


The IPR Policy says that to have strong and effective IPR laws, which balance the interests of rights owners with larger public interest, steps could be taken — including review of existing IP laws — to update and improve them or to remove anomalies and inconsistencies. The review will be done in consultation with stakeholders. The changes in the laws will be those relating to the Rules on patents, trademarks, copyrights and other IPRs, but the changes will not go beyond India’s commitments at the WTO-level.

India’s National Intellectual Property Rights (IPR) Policy

The new Intellectural Property Policy, unveiled by the Finance Minister is in compliance with TRIPS.

Finance Minister Arun Jaitley released India’s National Intellectual Property Rights (IPR) Policy recently. The Policy which is in compliance with WTO's (World Trade Organisation) agreement on TRIPS (Trade Related aspects of IPRs), aims to sustain entrepreneurship and boost Prime Minister Narendra Modi's pet scheme 'Make in India.' Here are the highlights:



>> The Policy aims to push IPRs as a marketable financial asset, promote innovation and entrepreneurship, while protecting public interest.

>>The plan will be reviewed every five years in consultation with stakeholders.

>> In order to have strong and effective IPR laws, steps would be taken — including review of existing IP laws — to update and improve them or to remove anomalies and inconsistencies.

>>The policy is entirely compliant with the WTO’s agreement on TRIPS.

>>Special thrust on awareness generation and effective enforcement of IPRs, besides encouragement of IP commercialisation through various incentives.

>> India will engage constructively in the negotiation of international treaties and agreements in consultation with stakeholders. The government will examine accession to some multilateral treaties which are in India's interest, and become a signatory to those treaties which India has de facto implemented to enable it to participate in their decision making process, the policy said.

>> It suggests making the department of industrial policy and promotion (DIPP) the nodal agency for all IPR issues. Copyrights related issues will also come under DIPP’s ambit from that of the Human Resource Development (HRD) Ministry.

>> Trademark offices have been modernised, and the aim is to reduce the time taken for examination and registration to just 1 month by 2017. The government has already hired around 100 new examiners for trademarks. Examination time for trademarks has been reduced from 13 months to 8 months, with the new target being to bring the time down to one month by March 2017.

>> Films, music, industrial drawings will be all covered by copyright.

>> The Policy also seeks to facilitate domestic IPR filings, for the entire value chain from IPR generation to commercialisation. It aims to promote research and development through tax benefits.

>> Proposal to create an effective loan guarantee scheme to encourage start-ups.

>> It also says “India will continue to utilise the legislative space and flexibilities available in international treaties and the TRIPS Agreement.” These flexibilities include the sovereign right of countries to use provisions such as Section 3(d) and CLs for ensuring the availability of essential and life-saving drugs at affordable prices.

>> The policy left the country’s patent laws intact and specifically did not open up Section 3(d) of the Patents Act, which sets the standard for what is considered an invention in India, for reinterpretation.

>>On compulsory licensing (CL), India has issued only CL for a cancer drug. Mr. Jaitley said, “We rarely exercise this power.” The statement assumes significance as developed countries, including the US, have raised concerns over India issuing the CL. As per the WTO norms, a CL can be invoked by a government allowing a company to produce a patented product without the consent of the patent owner in public interest. Under the Indian Patents Act, a CL can be issued for a drug if the medicine is deemed unaffordable, among other conditions, and the government grants permission to qualified generic drug makers to manufacture it.


>> The IPR policy favoured the government considering financial support for a limited period on sale and export of products based on IPRs generated from public-funded research.